Your browser doesn't support javascript.
loading
Sustained wash-resistant receptor activation responses of GPR119 agonists.
Hothersall, J Daniel; Bussey, Charlotte E; Brown, Alastair J; Scott, James S; Dale, Ian; Rawlins, Philip.
Afiliação
  • Hothersall JD; AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. Electronic address: daniel.hothersall@astrazeneca.com.
  • Bussey CE; AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK.
  • Brown AJ; AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK; Heptares Therapeutics Limited, Welwyn Garden City AL7 3AX, UK.
  • Scott JS; AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK.
  • Dale I; AstraZeneca, Cambridge Science Park, Cambridge CB4 0WG, UK.
  • Rawlins P; AstraZeneca, Cambridge Science Park, Cambridge CB4 0WG, UK.
Eur J Pharmacol ; 762: 430-42, 2015 Sep 05.
Article em En | MEDLINE | ID: mdl-26101059
ABSTRACT
G protein-coupled receptor 119 (GPR119) is involved in regulating metabolic homoeostasis, with GPR119 agonists targeted for the treatment of type-2 diabetes and obesity. Using the endogenous agonist oleoylethanolamide and a number of small molecule synthetic agonists we have investigated the temporal dynamics of receptor signalling. Using both a dynamic luminescence biosensor-based assay and an endpoint cAMP accumulation assay we show that agonist-driven desensitization is not a major regulatory mechanism for GPR119 despite robust activation responses, regardless of the agonist used. Temporal analysis of the cAMP responses demonstrated sustained signalling resistant to washout for some, but not all of the agonists tested. Further analysis indicated that the sustained effects of one synthetic agonist AR-231,453 were consistent with a role for slow dissociation kinetics. In contrast, the sustained responses to MBX-2982 and AZ1 appeared to involve membrane deposition. We also detect wash-resistant responses to AR-231,453 at the level of physiologically relevant responses in an endogenous expression system (GLP-1 secretion in GLUTag cells). In conclusion, our findings indicate that in a recombinant expression system GPR119 activation is sustained, with little evidence of pronounced receptor desensitization, and for some ligands persistent agonist responses continue despite removal of excess agonist. This provides novel understanding of the temporal responses profiles of potential drug candidates targetting GPR119, and highlights the importance of carefully examining the the mechanisms through which GPCRs generate sustained responses.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Acoplados a Proteínas G Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Acoplados a Proteínas G Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2015 Tipo de documento: Article